The Protein A Resin by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Protein A Resin Market:
https://www.thebusinessresearchcompany.com/report/protein-a-resin-global-market-report
According to The Business Research Company’s Protein A Resin, The protein a resin market size has grown strongly in recent years. It will grow from $1.53 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing biopharmaceutical production, growing adoption of monoclonal antibodies, expanding research and development activities, regulatory emphasis on biopharmaceutical quality, rising prevalence of chronic diseases.
The protein a resin market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to rising biosimilar development, focus on cost-efficiency, increasing investment in bioprocessing facilities, expansion of biopharmaceutical market in emerging economies, growing demand for personalized medicine. Major trends in the forecast period include single-use systems, technological advancements, demand in emerging markets, strategic collaborations and partnerships, focus on sustainable practices.
The increased R&D investments in pharmaceutical companies are expected to propel the growth of the protein A resin market forward. R&D refers to the process of researching and developing new drugs, therapies, technologies, or services that can be used to improve the health of patients. Protein A resin is used in several chromatography assays that are used in pharmaceutical development procedures as a chromatography medium. For instance, in 2022, Roche Holding AG, a Switzerland-based pharmaceuticals company spent the highest ever $16.79 billion on R&D which was an increase of 3.7% from 2021. Additionally, in 2022, Merck, a US-based pharmaceuticals company increased its R&D spending by 10% as compared to 2021, Merck spent $13.54 billion on R&D in 2022. As a result, the increased R&D investments in pharmaceutical companies is propelling the growth of the protein A resin market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9919&type=smp
The protein a resin market covered in this report is segmented –
1) By Type: Natural Protein A, Recombinant Protein A
2) By Matrix Type: Agarose-Based Protein A, Glass/Silica-Based Protein A, Organic Polymer-Based Protein A
3) By Application: Antibody Purification, Immunoprecipitation
4) By End User: Biopharmaceutical Manufacturers, Clinical Research Laboratories, Academic Institutes
Product innovations are a key trend gaining popularity in the protein A resin market. Major companies in the protein A resin market are introducing innovative solutions to sustain their position in the market. For instance, in February 2021, Repligen Corporation, a US-based developer of materials used in manufacturing biological drugs, launched NGL COVID-19 Spike Protein Affinity Resin in partnership with Navigo Proteins GmbH, a Germany-based biotechnology company. The uniqueness of the product is that it is a novel protein A resin that can be used for several vaccines for COVID-19 treatment.
The protein a resin market report table of contents includes:
Executive Summary
Protein A Resin Market Characteristics
Protein A Resin Market Trends And Strategies
Protein A Resin Market - Macro Economic Scenario
Global Protein A Resin Market Size and Growth
.
.
.
Global Protein A Resin Market Competitive Benchmarking
Global Protein A Resin Market Competitive Dashboard
Key Mergers And Acquisitions In The Protein A Resin Market
Protein A Resin Market Future Outlook and Potential Analysis
Appendix
Top 5 Major Key Players Are:
PerkinElmer Inc
GenScript Biotech Corporation
Agilent Technologies Inc
Repligen Corporation
Thermo Fisher Scientific Inc
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The global Protein A Resin Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2021-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.
The key players in the protein A resin market includes Agarose Bead Technologies (ABT), Bio-Rad Laboratories, Inc., Danaher Corporation, EMD Millipore, Expedeon Ltd, GE Healthcare, GenScript Corporation, Novasep, Purolite Life Sciences, Repligen, Sigma-Aldrich Corporation, Takara Bio Inc., Thermo Fisher Scientific and Tosoh Bioscience LLC among others.
An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Protein A Resin Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/protein-a-resin-market/download-sampleMarket DynamicsThe market is expected to witness substantial growth owing to growing demand for monoclonal antibodies.
In addition to this, the ongoing trend of outsourcing research activities resulting in higher demand for contract research organization is also contributing to the growth of protein A resin market.
Despite this, the high cost of Protein A resin may hinder market growth.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis.
The growth in this market is mainly driven by the growing demand for disposable pre-packed columns, increasing demand for therapeutic antibodies, and the increasing pharmaceutical R spending are expected to drive the growth of this market during the forecast period.
[140 Pages Report] The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period.The study involved four major activities in estimating the current size for the protein A resin market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Market DynamicsGrowing demand for disposable pre-packed columnsIncreasing demand for therapeutic antibodiesIncreasing pharmaceutical R spendingCOVID-19 Impact on the Protein A Resin MarketFor the past 30 years, monoclonal antibodies have transformed the way we treat various diseases—they have proven to be more effective, better tolerated, and easier to deliver than other treatments.
Researchers are optimistic that monoclonal antibodies could help prevent and treat early infections of COVID-19.
One of these is adalimumab, used to treat arthritis and Crohn’s disease; the University of Oxford recently launched a trial to look at its potential to treat people in care homes, funded by the COVID-19 Therapeutics Accelerator.
Eli Lilly and Company (US), in collaboration with AbCellera (Canada), launched the first human study of a potential COVID-19 antibody treatment in June 2020.Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962Chromatography is an essential step in the purification of monoclonal antibodies (mAbs).
The study involved four major activities in estimating the current size for the protein A resin market.
Exhaustive secondary research was done to collect information on the market and its different subsegments.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
Both top-down and bottom-up approaches were employed to estimate the complete market size.The growth in this market is mainly driven by the growing demand for disposable pre-packed columns, increasing demand for therapeutic antibodies, and the increasing pharmaceutical R spending are expected to drive the growth of this market during the forecast period.
However, the high cost of resins is expected to limit the growth of this market.According to the new market research report “Protein A Resin Market by Product (Agarose-based, Glass/Silica-based), Type (Recombinant Protein A, Natural Protein A), Application (Antibody Purification, Immunoprecipitation), & End User – Global Forecast to 2025″, published by MarketsandMarkets™, the market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period.Browse in-depth TOC on “Protein A Resin Market”103 – Tables42 – Figures137 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962The growth in this market is mainly driven by the growing demand for disposable pre-packed columns, increasing demand for therapeutic antibodies, and the increasing pharmaceutical R spending are expected to drive the growth of this market during the forecast period.By product, the Agarose-based Protein A segment is expected to account for the largest share of the Recombinant protein A market in 2020Based on product, the protein A resin market is segmented into agarose-based protein A, glass/silica-based protein A, and organic polymer-based protein A.
The large share of this segment can be attributed to the increasing demand for monoclonal antibodies for therapeutic as well as research purposes, which has driven the demand for protein A resins used in the downstream processing of these antibodies.By end-user, the pharmaceutical and biopharmaceutical companies end-user segment is expected to account for the largest share of the Recombinant protein A market in 2020Based on end user, the protein A resin market is segmented into pharmaceutical & biopharmaceutical companies, academic research institutes, and other end users.
The protein A resin market is predicted to rise at a notable pace in the forthcoming years, with growing research in monoclonal antibodies being a primary factor.
Interest of scientists and researchers in synthetic biology, and emphasis of the biopharmaceutical industry for use of protein-engineered products to develop protein-based drugs are some other key factors paving the growth of protein A resin market.The study offers a comprehensive analysis of the protein A resin market bringing to fore valuable insights that can help stakeholders identify opportunities and challenges.
The report tracks the protein A resin market across key regions, and includes in-depth assessment and accurate quantitative insights.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=78173Protein A Resin Market: Competitive Landscape The protein A resin market features a consolidated vendor landscape due to the presence of a few giant pharmaceutical companies.
As per the agreement, NGL- Impact A – the next-generation protein A ligand of the former will be commercialized by the latter using its new Praesto agarose jetting based bead technology.Some top-notch companies operating in the protein A resin market are GE Healthcare, Thermo Fisher Scientific Inc., Tosoh Corporation, Repligen Corporation, Merck KGaA, Purolite Corporation, and Novasep Holding SAS.Request COVID Analysis on Protein A Resin Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=78173Protein A Resin Market: Key TrendsIncreasing investments for protein-based research is one of the key factors driving the protein A resin market.
For example, MIT chemists have created tabletop automated flow synthesis machine that dramatically reduces the time taken for generating synthetic proteins.Request Customization on Protein A Resin Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=78173Increasing prevalence of chronic diseases resulting in demand for novel therapeutics for disease management bodes well for protein A resin market.
According to data of the United Nations Population Fund, individuals of 60 years and above comprise 12.3% of the world population, which is projected to increase to nearly 22% by 2050.
